At OCTSC, an expert delved into how to optimise patient enrollment to achieve retention and clinical trial success.
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Abbott ...
GlobalData on MSN
Europe’s path to maintaining clinical trial hotbed of innovation
The Annual Outsourcing in Clinical Trials & Clinical Trial Supply Nordics 2025 conference will gather experts to discuss ...
Introduction Therapeutic exercise has been used to improve cancer-related dysfunction. Recent studies suggest that exercise after chemotherapy can improve cancer-related cognitive impairment. However, ...
The best option is to deploy semi-autonomous models where agents recommend actions, but humans validate and approve those actions. As reliability grows over time, organizations will increase their ...
Gain perspective on how agentic AI can bridge eCOA, EDC, IRT, and CTMS platforms to reduce manual effort and improve ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has opined that Novo Nordisk ...
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering VesCell™ ...
A New York Times health reporter explains what makes a good study, and how she knows which papers merit an article.
CDMO conglomerate Almac is pouring $48 million into its eClinical offering via an investment that includes the launch of a ...
Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters ...
Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results